Australian cancer trials neglect sex differences, risking patient safety

medicalxpress.com

Australian cancer trials are failing to report sex differences, potentially endangering female patients. Fewer than 2% of trials report results separately by sex, hindering understanding of treatment effectiveness and side effects for women, who often experience more severe reactions. A study found reporting of sex-based analyses has declined since 2016, with no trials defining how sex or gender was determined.


With a significance score of 3.2, this news ranks in the top 8.6% of today's 30997 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers:


Australian cancer trials neglect sex differences, risking patient safety | News Minimalist